The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIPEL.L Regulatory News (IPEL)

  • There is currently no data for IPEL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

7 Oct 2020 16:15

RNS Number : 4201B
Impellam Group plc
07 October 2020
 

7 October 2020

 

Impellam Group plc

 

("Impellam" or the "Company")

 

Director/PDMR Shareholding

 

 

The Company has been informed that Lord Ashcroft KCMG PC, Chairman of Impellam, today purchased 50,000 ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares") at a price of 210 pence per Ordinary Share.

 

Enquiries:

Impellam Group plc

Julia Robertson, Chief Executive Officer

 

01582 692 658

Canaccord Genuity Ltd (Nomad and Sole Broker)

Bobbie Hilliam

Georgina McCooke

 

020 7523 8150

 

Note to Editors:

Impellam is the second largest 1  staffing company in the UK and sixth largest 2  Managed Services provider worldwide. Our vision is to be the world's most trusted staffing company - trusted by our people, our customers and our investors in equal measure.

We provide Managed Services and Specialist Staffing solutions across the UK, Europe, US, the Middle East and Australasia. We have over 3,200 Impellam people throughout our network of 17 market-leading brands across 165 worldwide locations.

Ultimately, Impellam Group's mission is to provide fulfilment and a sense of purpose to our people and to help customers build better businesses in a changing world.

For more information about Impellam Group please visit:  www.impellam.com  

1 By revenue (2017 published numbers)

2 By SUM (confirmed by Staffing Industry Analysts. Spend Under Management (SUM) is the total amount of client expenditure which our Managed Services brands manage on behalf of their clients. This equates to revenue earned where Impellam acts as principal plus gross billings to customers where Impellam acts as agent (2017 published numbers). Management use this measure as it reflects the total value of the client spend to the Group and not just the revenue generated

 

Further information is disclosed below in accordance with Article 19 of the Market Abuse Regulation:

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Michael Anthony Ashcroft

 

 

2

 

Reason for the notification

 

a)

 

Position/status

 

Chairman

 

b)

 

Initial notification /Amendment

 

Initial

 

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Impellam Group plc

 

b)

 

LEI

 

213800QCQWZBNJ2IUN83

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary shares of 1 pence each

 

ISIN: GB00B8HWGJ55

 

b)

 

Nature of the transaction

 

Purchase of Ordinary Shares

 

c)

 

Price(s) and volume(s)

 

 

Price(s)

 

Volume(s)

210p

50,000

 

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

N/A - single transaction

 

 

e)

 

Date of the transaction

 

7 October 2020

 

f)

 

Place of the transaction

 

AIMX

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFIEIELDIII
Date   Source Headline
11th Jan 20249:03 amRNSForm 8.5 (EPT/NON-RI) Impellam Group Plc
10th Jan 202411:05 amRNSForm 8.3 - Impellam Group PLC
5th Jan 20242:16 pmRNSForm 8.3 - Impellam Group Plc
27th Dec 20239:02 amRNSForm 8.3 - Impellam
22nd Dec 20237:00 amRNSPublication and posting of Scheme Document
19th Dec 20239:22 amRNSForm 8.5 (EPT/RI)
19th Dec 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
18th Dec 20231:41 pmRNSForm 8.3 - Impellam Group PLC
18th Dec 202311:03 amRNSForm 8.5 (EPT/RI)
18th Dec 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
15th Dec 20231:00 pmRNSForm 8.3 -Impellam Group plc
15th Dec 20237:55 amRNSForm 8.5 (EPT/RI)
15th Dec 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
14th Dec 202311:09 amRNSForm 8.3 - Impellam Group plc
14th Dec 20237:31 amRNSForm 8.5 (EPT/RI)
13th Dec 20231:49 pmRNSForm 8.3 - Impellam Group plc
13th Dec 20237:00 amRNSRecommended Acquisition
12th Dec 20234:44 pmRNSExtension of PUSU Deadline
12th Dec 202311:08 amRNSForm 8.3 - Impellam Group plc
12th Dec 20237:46 amRNSForm 8.5 (EPT/RI)
12th Dec 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
11th Dec 202312:00 pmRNSForm 8.3 - Impellam Group plc
11th Dec 202310:53 amRNSForm 8.5 (EPT/RI)
11th Dec 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
8th Dec 202312:49 pmRNSForm 8.3 - Impellam Group plc
8th Dec 202310:14 amRNSForm 8.5 (EPT/RI)
7th Dec 202312:25 pmRNSForm 8.3 - Impellam Group plc
6th Dec 202312:35 pmRNSForm 8.3 - Impellam Group plc
6th Dec 202310:49 amRNSForm 8.5 (EPT/RI)
6th Dec 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
5th Dec 20234:00 pmRNSExtension of PUSU Deadline
5th Dec 20231:13 pmRNSForm 8.3 - Impellam Group plc
5th Dec 202310:29 amRNSForm 8.5 (EPT/RI)
5th Dec 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
4th Dec 202310:30 amRNSForm 8.3 - Impellam Group plc
1st Dec 202311:55 amRNSForm 8.3 - Impellam Group plc
30th Nov 202312:13 pmRNSForm 8.3 - Impellam Group plc
30th Nov 202310:45 amRNSForm 8.5 (EPT/RI)
30th Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
29th Nov 20234:43 pmRNSExtension of PUSU Deadline
29th Nov 202312:04 pmRNSForm 8.3 - Impellam Group plc
29th Nov 202311:47 amRNSForm 8.5 (EPT/RI)
29th Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
28th Nov 202312:09 pmRNSForm 8.3 - Impellam Group plc
28th Nov 202311:18 amRNSForm 8.5 (EPT/RI)
28th Nov 20237:00 amRNSTransaction in Own Shares & Rule 2.9 Announcement
27th Nov 202310:45 amRNSForm 8.3 - Impellam Group Plc
24th Nov 202311:35 amRNSForm 8.3 - Impellam Group Plc
23rd Nov 202312:29 pmRNSForm 8.3 - Impellam Group plc
22nd Nov 202311:55 amRNSForm 8.3 - Impellam Group Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.